Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RORB | Q92753 | 3/20 | 0.49 |
| ▸ | RORC | P51449 | 2/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
| ▸ | QPCT | Q16769 | 1/20 | 0.45 |
| ▸ | QPCTL | Q9NXS2 | 1/20 | 0.45 |
| ▸ | IDO1 | P14902 | 3/20 | 0.44 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.42 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.42 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.41 |
| ▸ | RECQL | P46063 | 1/20 | 0.40 |
| ▸ | PIK3R1 | P27986 | 1/20 | 0.40 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1094348 | 0.80 | PIM1 (0.49) | RORBRORCALDH1A1HPGDHSD17B10 | |
| SCHEMBL27955462 | 0.78 | HPGD (0.47) | ALDH1A1HPGDBCL2L1HSD17B10QPCT | |
| SCHEMBL15673169 | 0.78 | IDO1 (0.44) | RORBRORCIDO1ADORA2AADORA1 | |
| SCHEMBL4928287 | 0.78 | IDO1 (0.44) | RORBRORCALDH1A1IDO1ADORA2A | |
| SCHEMBL1415495 | 0.78 | ADORA2A (0.49) | RORBRORCALDH1A1HSD17B10IDO1 | |
| SCHEMBL28493426 | 0.78 | ALDH1A1 (0.47) | ALDH1A1HPGDBCL2L1HSD17B10QPCT | |
| SCHEMBL4027001 | 0.75 | IDO1 (0.55) | IDO1ADORA2AADORA1TRPA1RECQL | |
| SCHEMBL6501884 | 0.74 | RORC (0.46) | RORBRORCIDO1ADORA2AADORA1 | |
| SCHEMBL2329610 | 0.74 | ADORA2A (0.56) | IDO1ESR2ADORA2AADORA1TRPA1 | |
| SCHEMBL29461217 | 0.74 | ADORA2A (0.56) | IDO1ESR2ADORA2AADORA1TRPA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105315319-B | Hepatitis C virus inhibitor and application thereof | 南京圣和药业股份有限公司 | 2020-11-20 | — | — | CN | disclosed |
| CN-103827118-B | Bicyclic pyrimidin ketone compound | GLAXO GROUP LTD. (GB) | 2016-03-09 | — | — | CN | disclosed |
| CN-103827118-A | Bicyclic pyrimidone compounds | GLAXO GROUP LTD | 2014-05-28 | — | — | CN | disclosed |
| US-7683065-B2 | Pyridines useful as modulators of ion channels | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2010-03-23 | — | — | US | disclosed |
| US-7683065-B2 | Pyridines useful as modulators of ion channels | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2010-03-23 | — | — | US | disclosed |
| US-7683065-B2 | Pyridines useful as modulators of ion channels | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2010-03-23 | — | — | US | disclosed |
| EP-1877381-A1 | PYRIDINES USEFUL AS MODULATORS OF ION CHANNELS | Vertex Pharmaceuticals Incorporated (US) | 2008-01-16 | — | — | EP | disclosed |
| US-20070082889-A1 | Pyridines useful as modulators of ion channels | VERTEX PHARMACEUTICALS INCORPORATED | 2007-04-12 | — | — | US | disclosed |
| US-20070082889-A1 | Pyridines useful as modulators of ion channels | VERTEX PHARMACEUTICALS INCORPORATED | 2007-04-12 | — | — | US | disclosed |
| US-20070082889-A1 | Pyridines useful as modulators of ion channels | VERTEX PHARMACEUTICALS INCORPORATED | 2007-04-12 | — | — | US | disclosed |
| WO-2006119390-A1 | PYRIDINES USEFUL AS MODULATORS OF ION CHANNELS | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2006-11-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070082889-A1 | Pyridines useful as modulators of ion channels | KCNH2, KCNQ1, KCNQ2 | RORB 4007/4885RORC 3378/4885ALDH1A1 2107/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.